Detailed Information
Cited 15 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
First-line pembrolizumab plus chemotherapy versus chemotherapy in advanced esophageal cancer: Longer-term efficacy, safety, and quality-oflife results from the phase 3 KEYNOTE-590 study
- Authors
- Metges, JP[Metges, Jean-Philippe]; Kato, K[Kato, Ken]; Sun, JM[Sun, Jong-Mu]; Shah, MA[Shah, Manish A.]; Enzinger, PC[Enzinger, Peter C.]; Adenis, A[Adenis, Antoine]; Doi, T[Doi, Toshihiko]; Kojima, T[Kojima, Takashi]; Li, ZG[Li, Zhigang]; Kim, SB[Kim, Sung-Bae]; Cho, BC[Cho, Byoung Chul]; Mansoor, W[Mansoor, Wasat]; Li, SH[Li, Shau-Hsuan]; Sunpaweravong, P[Sunpaweravong, Patrapim]; Alsina, M[Alsina, Maria]; Buchschacher, GL[Buchschacher, Gary L.]; Wu, JM[Wu, Jimin]; Shah, S[Shah, Sukrut]; Bhagia, P[Bhagia, Pooja]; Shen, L[Shen, Lin]
- Issue Date
- 1-Feb-2022
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.40, no.4
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 40
- Number
- 4
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.